Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results(Nature Medicine, 10.1038/s41591-022-02170-x)

Isabella C. Glitza Oliva, Sherise D. Ferguson, Roland Bassett, Alexandra P. Foster, Ida John, Tarin D. Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Dett, Carol Lacey, Natalie Jackson, Theresa Rodgers, Suzanne Phillips, Sheila Duncan, Lauren Haydu, Ruitao Lin, Rodabe N. Amaria, Michael K. Wong, Adi DiabCassian Yee, Sapna P. Patel, Jennifer L. McQuade, Grant M. Fischer, Ian E. McCutcheon, Barbara J. O’Brien, Sudhakar Tummala, Matthew Debnam, Nandita Guha-Thakurta, Jennifer A. Wargo, Fernando C.L. Carapeto, Courtney W. Hudgens, Jason T. Huse, Michael T. Tetzlaff, Elizabeth M. Burton, Hussein A. Tawbi, Michael A. Davies

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-022-02170-x, published online 30 March 2023. In the version of the article initially published, Fernando C. L. Carapeto (Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA), Courtney W. Hudgens (Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA), Jason T. Huse (Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) and Michael T. Tetzlaff (Department of Pathology, University of California San Francisco, San Francisco, CA, USA) were mistakenly omitted from the author list and contributions (performed the pathology and associated figures) and have now been added in the HTML and PDF versions of the article.

Original languageEnglish (US)
Pages (from-to)1787
Number of pages1
JournalNature Medicine
Volume30
Issue number6
DOIs
StatePublished - Jun 2024
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results(Nature Medicine, 10.1038/s41591-022-02170-x)'. Together they form a unique fingerprint.

Cite this